APA (7th ed.) Citation

Ross, D. M., Heidel, F. H., Perkins, A. C., Reiter, A., Crodel, C., Riley, C., . . . Harrison, C. N. (2025). ADORE: An open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis. Blood advances, 9(16), . https://doi.org/10.1182/bloodadvances.2025015860

Chicago Style (17th ed.) Citation

Ross, David M., et al. "ADORE: An Open Platform Study of Ruxolitinib in Combination with Other Novel Therapies in Patients with Myelofibrosis." Blood Advances 9, no. 16 (2025). https://doi.org/10.1182/bloodadvances.2025015860.

MLA (9th ed.) Citation

Ross, David M., et al. "ADORE: An Open Platform Study of Ruxolitinib in Combination with Other Novel Therapies in Patients with Myelofibrosis." Blood Advances, vol. 9, no. 16, 2025, https://doi.org/10.1182/bloodadvances.2025015860.